# | Title | Journal | Year | Citations |
---|
1 | Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer | International Journal of Clinical Oncology | 2018 | 1,187 |
2 | Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer | International Journal of Clinical Oncology | 2020 | 1,123 |
3 | Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer | International Journal of Clinical Oncology | 2012 | 658 |
4 | Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer | International Journal of Clinical Oncology | 2015 | 548 |
5 | Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version | International Journal of Clinical Oncology | 2008 | 299 |
6 | The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma | International Journal of Clinical Oncology | 2004 | 281 |
7 | PD-1/PD-L1 blockade in cancer treatment: perspectives and issues | International Journal of Clinical Oncology | 2016 | 255 |
8 | PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer | International Journal of Clinical Oncology | 2017 | 241 |
9 | Biological and clinical implications of EGFR mutations in lung cancer | International Journal of Clinical Oncology | 2006 | 194 |
10 | Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update | International Journal of Clinical Oncology | 2008 | 185 |
11 | Current status of oral cancer treatment strategies: surgical treatments for oral squamous cell carcinoma | International Journal of Clinical Oncology | 2014 | 182 |
12 | Circulating tumor cells: clinical validity and utility | International Journal of Clinical Oncology | 2017 | 170 |
13 | The role of cancer registries in cancer control | International Journal of Clinical Oncology | 2008 | 167 |
14 | Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials | International Journal of Clinical Oncology | 2014 | 166 |
15 | Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention | International Journal of Clinical Oncology | 2010 | 162 |
16 | Radiobiological basis of SBRT and SRS | International Journal of Clinical Oncology | 2014 | 159 |
17 | Boron neutron capture therapy (BNCT): a unique role in radiotherapy with a view to entering the accelerator-based BNCT era | International Journal of Clinical Oncology | 2020 | 156 |
18 | Management of intraocular retinoblastoma and ocular prognosis | International Journal of Clinical Oncology | 2004 | 154 |
19 | Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers | International Journal of Clinical Oncology | 2008 | 154 |
20 | Oral premalignant lesions: from a clinical perspective | International Journal of Clinical Oncology | 2011 | 140 |
21 | Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management | International Journal of Clinical Oncology | 2009 | 139 |
22 | Multiple primary cancer: an experience at the Cancer Institute Hospital with special reference to colorectal cancer | International Journal of Clinical Oncology | 2003 | 137 |
23 | Cardiac metastases | International Journal of Clinical Oncology | 2008 | 137 |
24 | Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: molecular mechanisms of carcinogenesis | International Journal of Clinical Oncology | 2010 | 136 |
25 | Frequency of brain metastases in non-small-cell lung cancer, and their association with epidermal growth factor receptor mutations | International Journal of Clinical Oncology | 2015 | 133 |
26 | Malignant ascites: pathophysiology and treatment | International Journal of Clinical Oncology | 2013 | 131 |
27 | Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer | International Journal of Clinical Oncology | 2008 | 129 |
28 | Updated statistical data for malignant melanoma in Japan | International Journal of Clinical Oncology | 2001 | 124 |
29 | Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer? | International Journal of Clinical Oncology | 2015 | 122 |
30 | Current issues and perspectives in PD-1 blockade cancer immunotherapy | International Journal of Clinical Oncology | 2020 | 120 |
31 | Tumor angiogenesis—characteristics of tumor endothelial cells | International Journal of Clinical Oncology | 2016 | 119 |
32 | Trastuzumab and breast cancer: developments and current status | International Journal of Clinical Oncology | 2006 | 117 |
33 | Anxiety, depression and quality of life in colorectal cancer patients | International Journal of Clinical Oncology | 2005 | 116 |
34 | Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment | International Journal of Clinical Oncology | 2020 | 115 |
35 | Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer | International Journal of Clinical Oncology | 2007 | 112 |
36 | A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer | International Journal of Clinical Oncology | 2010 | 111 |
37 | The impact of real-time tissue elasticity imaging (elastography) on the detection of prostate cancer: clinicopathological analysis | International Journal of Clinical Oncology | 2007 | 110 |
38 | Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 15-3) in breast cancer | International Journal of Clinical Oncology | 2008 | 108 |
39 | A clinical overview of familial adenomatous polyposis derived from the database of the Polyposis Registry of Japan | International Journal of Clinical Oncology | 2004 | 106 |
40 | Treatment of lymphedema with lymphaticovenular anastomoses | International Journal of Clinical Oncology | 2005 | 106 |
41 | Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cervical cancer | International Journal of Clinical Oncology | 2019 | 106 |
42 | Molecular pathogenesis of bladder cancer | International Journal of Clinical Oncology | 2008 | 105 |
43 | Japan Society of Gynecologic Oncology guidelines 2011 for the treatment of uterine cervical cancer | International Journal of Clinical Oncology | 2015 | 104 |
44 | Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with advanced non-small-cell lung cancer treated with nivolumab | International Journal of Clinical Oncology | 2018 | 103 |
45 | Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan | International Journal of Clinical Oncology | 2015 | 102 |
46 | Targeting metabolic reprogramming in KRAS-driven cancers | International Journal of Clinical Oncology | 2017 | 102 |
47 | Billroth 1 versus Roux-en-Y reconstructions: a quality-of-life survey at 5 years | International Journal of Clinical Oncology | 2007 | 101 |
48 | Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer | International Journal of Clinical Oncology | 2013 | 100 |
49 | The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV | International Journal of Clinical Oncology | 2019 | 100 |
50 | Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance | International Journal of Clinical Oncology | 2015 | 98 |